INSMED IncINSM

Market cap

$11.1B

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023
Product revenues, net	4	-	12	-	-	-	-	10	136	164	188	245	305
Cost of Goods and Services Sold	-	-	-	-	-	-	-	2	24	40	44	55	66
Research and development	28	30	44	56	74	123	110	145	132	181	273	398	571
General and Administrative Expense	12	13	22	31	43	51	79	168	211	204	234	266	345
Amortization of intangible assets	-	-	-	-	-	-	-	1	5	5	5	5	5
Change in fair value of deferred and contingent consideration liabilities	-	-	-	-	-	-	-	-	-	-	7	-21	29
Total operating expenses	-	-	-	-	-	-	-	317	348	430	564	703	1,015
Operating loss	-62	-42	-55	-87	-117	-173	-189	-307	-235	-265	-375	-457	-710
Investment income	2	2	0	0	0	1	2	10	10	2	0	11	42
Interest expense	0	1	2	2	3	3	6	25	28	30	40	26	82
Unrealized Gain (Loss) on Derivatives	-	-	-	-	-	-	-	-	-	-	-	-2	0
Loss on extinguishment of debt	-	-	-	-	-	-	-	-2	-	-	-18	-	-
Other income (expense), net	-	-	-0	0	-0	0	0	1	-1	0	-3	-6	2
Loss before income taxes	-60	-41	-57	-90	-120	-176	-193	-324	-254	-293	-436	-480	-747
Income Tax Expense (Benefit)	-	-	-1	-10	-2	0	-0	0	1	1	-2	1	3
Net loss	-60	-41	-56	-79	-118	-176	-193	-324	-254	-294	-435	-482	-750
Earnings Per Share, Basic	-2.95	-	-	-	-	-	-	-	-	-	-3.88	-3.91	-5.34
Earnings Per Share, Diluted	-2.95	-	-	-	-	-	-	-	-	-	-3.88	-3.91	-5.34
Net loss	-69	-41	-56	-79	-	-176	-193	-324	-254	-294	-435	-482	-750
Foreign currency translation and other (losses) gains	-	-	-	-	-	-0	0	-0	-0	0	1	0	-2
Unrealized gain (loss) on marketable securities	-	-	-	-	-	-	-	-	-	-	-	-1	1
Total comprehensive loss	-	-41	-56	-79	-	-176	-193	-324	-254	-294	-434	-482	-751